FDA Staff Question P&G Female Sex-Drive Patch
554838
U.S. regulatory reviewers said on  Wednesday it was unclear if Procter & Gamble Co.'s testosterone  patch for boosting sexual desire in women produces meaningful  benefit or is safe over the long term.
37763
The US Food and Drug Administration (FDA) announced on Monday that Mifepristoneâs label will be changed to acknowledge that there are risks associated with any abortion, and that physicians prescribing the drug should instruct their patients to contact
150337
Two television advertisements for Pfizer Inc.'s impotence drug Viagra should be withdrawn for claiming a return of sexual desire and omitting key information, the Food and Drug Administration said in a letter to the company released on Monday.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
656312
The Food and Drug Administration has ordered Pfizer (PFE:NYSE - news - research) to pull two television ads promoting the impotence treatment Viagra because the agency said the ads don&#39;t provide information about the drug&#39;s potential side effects.
303304
Wyeth on Wednesday faced   accusations that one of its hormone replacement therapy (HRT)   drugs caused breast cancer in a 67-year-old woman as one of the   thousands of trials the drug maker is facing over the treatment   got underway.
378600
The hormone patch Intrinsa aims to restore women's lost libido, but some health experts are concerned that potential health risks may eclipse the benefit of marginally better sex.
50866
WASHINGTON  - The US Food and Drug Administration (news - web sites) (FDA (news - web sites)) banned the import of two male sexual stimulant diet supplements sold on the Internet, saying they contain an undeclared prescription drug ingredient.
272661
GAITHERSBURG, Md.  - Procter & Gamble's skin patch  to boost sex drive in women may pose serious long-term risks  and should not be approved without further study, critics told  a U.S. advisory panel on Thursday.
763100
Procter & Gamble Co. PG.N said on  Tuesday U.S. regulators have granted priority review for its  experimental drug to treat reduced sex drive in women with  menopause triggered by surgery.
410491
GAITHERSBURG, Md.  - Procter & Gamble Co.'s  testosterone patch for boosting female sex drive needs  longer-term testing for serious side effects before it can win  approval, a U.S. advisory panel unanimously ruled on Thursday.
478566
Federal health advisers say there&#39;s not enough information to make sure a hormone patch that revives women&#39;s libido is safe for long-term use.
529585
WASHINGTON - A federal scientific advisory panel meets tomorrow to consider whether to recommend that a skin patch to enhance women&#39;s desire for sex should be licensed as a new drug.
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a
691976
Washington, Dec 16 : One-fifth of the US Food and Drug Administration (FDA) scientists surveyed as part of an official review have said they had been pressured to recommend approval of a new drug despite their reservations about its safety, effectiveness
623765
MARYLAND - Women may be ready for Viagra, but Viagra is not yet ready for women. The first drug to treat female sexual dysfunction has been delayed because of safety concerns.
191470
Procter &amp; Gamble&#39;s skin patch to boost sex drive in women may pose serious long-term risks and should not be approved without further study, critics told a US advisory panel on Thursday.